Valion Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.22	12.65	2	3.4	3.52	12.98
Cash & Short-Term Investments	7.22	12.65	2	3.4	3.52	12.98
Cash Growth	978.48%	531.62%	-41.03%	-3.47%	-72.89%	1142.82%
Accounts Receivable	-	-	-	0.17	0.11	0.09
Inventory	0.75	-	-	0.76	0.86	0.43
Other Current Assets	1.61	0.5	0.69	0.33	0.82	0.79
Total Current Assets	8.65	13.01	2.64	4.65	5.31	14.29
Net Property, Plant & Equipment	22.73	12.64	0	0.47	0.54	0.7
Other Intangible Assets	2.24	2.24	-	-	-	-
Goodwill	3.46	3.46	-	-	-	-
Other Long-Term Assets	0.21	0.12	0.12	0.03	0.03	0.05
Total Assets	38.22	31.61	2.81	5.16	5.88	15.04
Accounts Payable	0.63	0.26	0.13	0.71	1.32	0.79
Accrued Expenses	1.49	0.38	0.13	0.5	0.39	0.27
Current Portion of Leases	0.49	-	-	0.19	0.16	0.16
Other Current Liabilities	0	0.01	0.02	-	-	-
Total Current Liabilities	2.62	0.65	0.27	1.4	1.88	1.22
Long-Term Debt	6.9	6.45	-	-	-	-
Long-Term Leases	9.64	-	-	0.18	0.37	0.55
Other Long-Term Liabilities	0.51	0.34	-	-	-	-
Total Long-Term Liabilities	17.05	6.79	-	0.18	0.37	0.55
Total Liabilities	19.67	7.44	0.27	1.58	2.25	1.76
Common Stock	0	0	0	-	-	0
Additional Paid-in Capital	70.09	69.39	46.08	41.47	33.27	32.82
Retained Earnings	-59.03	-52.6	-43.54	-37.89	-29.64	-19.55
Total Common Shareholders' Equity	11.06	16.8	2.54	3.58	3.63	13.27
Minority Interest	7.49	7.37	-	-	-	-
Shareholders' Equity	18.55	24.17	2.54	3.58	3.63	13.27
Total Liabilities & Equity	38.22	31.61	2.81	5.16	5.88	15.04
Total Debt	17.03	6.45	0	0.37	0.53	0.71
Net Cash (Debt)	-9.82	6.19	2	3.03	2.99	12.27
Net Cash Growth	-	209.24%	-33.84%	1.31%	-75.65%	-
Net Cash Per Share	-5.67	5.36	6.97	64.87	104939.20	1193949.95
Book Value	11.06	16.8	2.54	3.58	3.63	13.27
Book Value Per Share	6.39	14.54	8.82	76.74	127529.00	1291760.00
Tangible Book Value	5.36	11.1	2.54	3.58	3.63	13.27
Tangible Book Value Per Share	3.10	9.60	8.82	76.74	127529.00	1291760.00

SEC Filings: 10-K · 10-Q